OMEGA THERAPEUTICS, INC.

Analyst Reco. Omega Therapeutics, Inc.

Equities

OMGA

US68217N1054

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1.98 ^USD	+1.02%		-7.04%	-34.22%

May. 29	Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer	CI
May. 06	Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Trims Price Target on Omega Therapeutics to $9 From $10, Maintains Overweight Rating	Apr. 03	MT
Chardan Cuts Price Target on Omega Therapeutics to $7 From $12, Keeps Buy Rating	Apr. 01	MT
HC Wainwright Adjusts Omega Therapeutics' Price Target to $12 From $11, Maintains Buy Rating	Nov. 13	MT
Wedbush Lowers Omega Therapeutics' PT to $12 From $19, Adjusts Financing Assumptions; Keeps Outperform Rating	Nov. 10	MT
Wedbush Lowers Omega Therapeutics' Price Target to $19 From $23, Adjusts Financing Assumptions; Keeps Outperform Rating	23-05-05	MT
JonesTrading Initiates Omega Therapeutics at Buy With $11 Price Target	23-03-10	MT
Piper Sandler Adjusts Omega Therapeutics' Price Target to $10 From $8, Keep Overweight Rating	23-03-03	MT
Wedbush Cuts Omega Therapeutics's Price Target to $23 From $25, Maintains Outperform Rating	23-03-01	MT
HC Wainwright Initiates Omega Therapeutics With Buy Rating, Sets Price Target at $11	22-12-08	MT
Wedbush Lifts Omega Therapeutics' Price Target to $25 From $24, Keeps Outperform Rating	22-11-09	MT
Chardan Starts Omega Therapeutics at Buy With $12 Price Target	22-09-23	MT
Goldman Sachs Adjusts Price Target for Omega Therapeutics to $4 From $7, Retains Neutral Rating	22-05-24	MT
Piper Sandler Lowers Omega Therapeutics' Price Target to $7 From $30, Maintains Overweight Rating	22-05-23	MT
Wedbush Adjusts Price Target on Omega Therapeutics to $24 From $30, Keeps Outperform Rating	22-05-06	MT
Wedbush Adjusts Omega Therapeutics' Price Target to $30 From $36, Keeps Outperform Rating	22-03-11	MT
OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target	21-08-24	MT
OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Target	21-08-24	MT
OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price Target	21-08-24	MT
OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target	21-08-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer